Content about Corporate crime

May 16, 2012
Results from phase-3 trial of Pfizer cancer drug disappoint

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 15, 2012
Reports: Pfizer 'quietly' giving up on Lipitor marketing

Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.

May 10, 2012
FDA panel recommends approval for Pfizer RA drug

A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.

April 23, 2012
Pfizer sells nutrition business to Nestlé

Pfizer is selling its nutrition business to Nestle for $11.85 billion, Pfizer said Monday.

April 12, 2012
Pfizer Consumer Healthcare to refurbish after-school trolley in Albany, N.Y.

Pfizer Consumer Healthcare on Wednesday partnered with an Albany, N.Y. organization, the CURE Foundation, to refurbish a trolley to be used to shuttle area youth to and from after-school activities.

April 9, 2012
Pfizer brings Lipitor marketing campaign to Walgreens Chicago flagship store

Drug maker Pfizer is taking a marketing campaign for one of its drugs to Walgreens' Chicago flagship store to raise awareness about high cholesterol and healthy eating, the company said Monday.

April 2, 2012
Super PBM merger approved; NACDS, NCPA file emergency motion to block merger

The controversial merger between Express Scripts and Medco was completed Monday morning, according to a press release issued by both Express Scripts and the Federal Trade Commission.

March 29, 2012
FTC testifies on anticompetition potential of an independent pharmacy bloc

The U.S. House Judiciary Committee's Subcommittee on Intellectual Property, Competition and the Internet on Thursday morning heard testimony regarding H.R. 1946, "Preserving Our Hometown Independent Pharmacies Act of 2011."

February 21, 2012
Pfizer inks generics deal with Chinese drug maker

Pfizer has signed a deal worth more than $500 million with a Chinese drug maker to make generic drugs for China and other markets, the companies said.

February 17, 2012
Pfizer cancer drug hits BioPlus' shelves

A specialty pharmacy provider has begun selling a drug made by Pfizer for treating kidney cancer.

February 15, 2012
FDA accepts Pfizer application for genetic disease drug

The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.

February 15, 2012
Managed care plans prefer generic over branded Lipitor

Managed care and prescription plans are working to switch patients to generic versions of Pfizer's Lipitor despite the drug maker's efforts to reduce costs for the branded version, a new study suggested.

February 10, 2012
Report: FTC to rule on Express Scripts, Medco merger within 30 days

Bloomberg on Friday reported that Express Scripts intends to inform the Federal Trade Commission that the company has delivered all the data requested regarding its purchase of Medco Health Solutions on Friday, which will trigger a 30-day period for a decision from the FTC.

January 31, 2012
FDA approves Lilly-Boehringer Ingelheim diabetes drug

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

January 27, 2012
FDA approves Pfizer's Inlyta for advanced kidney cancer

The Food and Drug Administration has approved a drug made by Pfizer for treating advanced kidney cancer, the agency said Friday.

January 26, 2012
Pfizer, J&J subsidiary, charity group launch Alzheimer's Challenge 2012

Pfizer is partnering with a division of Johnson & Johnson and a charity organization to launch an initiative to award funding to projects designed to improve the diagnostic identification and tracking of Alzheimer's disease.

December 22, 2011
Pfizer announces Embeda post-market trial results

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

December 16, 2011
Lyrica produces 'significant' improvement in restless legs syndrome

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

December 8, 2011
FDA panel votes in favor of Pfizer kidney cancer drug

A Food and Drug Administration panel of 13 advisers has voted in favor of a drug made by Pfizer for treating kidney cancer, the drug maker said Wednesday.

December 6, 2011
Pfizer's Toviaz safe, effective in treating overactive bladder in elderly patients

A drug made by Pfizer appears to work in treating overactive bladder in elderly patients, according to results of a clinical trial released Monday.

December 1, 2011
Senators look into Pfizer-PBM deal for Lipitor

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

November 22, 2011
Pfizer acquiring Excaliard Pharmaceuticals

Pfizer will acquire a San Diego-based drug maker focused on treatments for skin scarring, the company said Tuesday.

October 28, 2011
Pfizer completes Icagen acquisition

Icagen officially is a wholly owned subsidiary of Pfizer.

October 20, 2011
Prasco to market authorized generic Zyprexa

Prasco Labs will make authorized generic versions of two psychiatric drugs made by Eli Lilly under a partnership between the two companies announced Thursday.

September 21, 2011
Pfizer moves forward in Icagen acquisition deal

The offering period for Pfizer's acquisition of Icagen has expired, allowing the former to purchase more than 5 million shares in the company, Pfizer said.

© 2012 Drug Store News. All Rights Reserved.